Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Hepatic Veno-Occlusive Disease”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Not applicableStudy completedNCT03032016
What this trial is testing

European VOD Registry

Who this might be right for
Hepatic Veno-Occlusive Disease
Jazz Pharmaceuticals 176
Large-scale testing (Phase 3)Study completedNCT00358501
What this trial is testing

Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease in Hematopoetic Stem Cell Transplant Patients

Who this might be right for
Severe Hepatic Veno-Occlusive Disease
Jazz Pharmaceuticals 134
Not applicableUnknownNCT04386772
What this trial is testing

Portal Vein Embolization Using Coils Plus TAGM vs Multiple Coils for Patients With Perihilar Cholangiocarcinoma or Hepatocellular Carcinoma

Who this might be right for
Portal Vein OcclusionCholangiocarcinoma, PerihilarHepatocellular Carcinoma+1 more
Eastern Hepatobiliary Surgery Hospital 56
Early research (Phase 1)WithdrawnNCT00062543
What this trial is testing

Hepatic Artery Infusion of CD34+ Cells

Who this might be right for
Stem Cell TransplantationLiver Diseases
M.D. Anderson Cancer Center
Not applicableLooking for participantsNCT06895798
What this trial is testing

Differential Impact of Pringle and Portal Vein Occlusion on Myocardial Injury After Non-Cardiac Surgeries.

Who this might be right for
Myocardial Injury After Non-Cardiac SurgeryIschemia Reperfusion Injury
Beijing Tsinghua Chang Gung Hospital 800
Testing effectiveness (Phase 2)Study completedNCT00003966
What this trial is testing

Defibrotide in Treating Patients With Liver Damage Following Peripheral Stem Cell Transplantation

Who this might be right for
Veno-occlusive Disease
Dana-Farber Cancer Institute 151